245 related articles for article (PubMed ID: 22911765)
1. Potential role for PAD2 in gene regulation in breast cancer cells.
Cherrington BD; Zhang X; McElwee JL; Morency E; Anguish LJ; Coonrod SA
PLoS One; 2012; 7(7):e41242. PubMed ID: 22911765
[TBL] [Abstract][Full Text] [Related]
2. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours.
Cherrington BD; Mohanan S; Diep AN; Fleiss R; Sudilovsky D; Anguish LJ; Coonrod SA; Wakshlag JJ
J Comp Pathol; 2012; 147(2-3):139-46. PubMed ID: 22520816
[TBL] [Abstract][Full Text] [Related]
4. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
[TBL] [Abstract][Full Text] [Related]
5. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.
Zhang X; Bolt M; Guertin MJ; Chen W; Zhang S; Cherrington BD; Slade DJ; Dreyton CJ; Subramanian V; Bicker KL; Thompson PR; Mancini MA; Lis JT; Coonrod SA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13331-6. PubMed ID: 22853951
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Lee HJ; Joo M; Abdolrasulnia R; Young DG; Choi I; Ware LB; Blackwell TS; Christman BW
J Biol Chem; 2010 Dec; 285(51):39655-62. PubMed ID: 20937835
[TBL] [Abstract][Full Text] [Related]
7. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
8. Targeted H3R26 deimination specifically facilitates estrogen receptor binding by modifying nucleosome structure.
Guertin MJ; Zhang X; Anguish L; Kim S; Varticovski L; Lis JT; Hager GL; Coonrod SA
PLoS Genet; 2014 Sep; 10(9):e1004613. PubMed ID: 25211228
[TBL] [Abstract][Full Text] [Related]
9. Modulation of calcium-induced cell death in human neural stem cells by the novel peptidylarginine deiminase-AIF pathway.
U KP; Subramanian V; Nicholas AP; Thompson PR; Ferretti P
Biochim Biophys Acta; 2014 Jun; 1843(6):1162-71. PubMed ID: 24607566
[TBL] [Abstract][Full Text] [Related]
10. Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2.
Zheng L; Nagar M; Maurais AJ; Slade DJ; Parelkar SS; Coonrod SA; Weerapana E; Thompson PR
Biochemistry; 2019 Jul; 58(27):3042-3056. PubMed ID: 31243954
[TBL] [Abstract][Full Text] [Related]
11. Small molecule activates citrullination through targeting PAD2.
Zhang X; Shen M; Zhu H; Zhang J; Yang M; Su K; Zhang Y; Fu W; Ke X; Qu Y
Philos Trans R Soc Lond B Biol Sci; 2023 Nov; 378(1890):20220248. PubMed ID: 37778388
[TBL] [Abstract][Full Text] [Related]
12. Histone Citrullination Represses MicroRNA Expression, Resulting in Increased Oncogene mRNAs in Somatolactotrope Cells.
DeVore SB; Young CH; Li G; Sundararajan A; Ramaraj T; Mudge J; Schilkey F; Muth A; Thompson PR; Cherrington BD
Mol Cell Biol; 2018 Oct; 38(19):. PubMed ID: 29987187
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism.
Dreyton CJ; Knuckley B; Jones JE; Lewallen DM; Thompson PR
Biochemistry; 2014 Jul; 53(27):4426-33. PubMed ID: 24989433
[TBL] [Abstract][Full Text] [Related]
15. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
16. Activation of Peptidylarginine Deiminase in the Salivary Glands of
Rodríguez-Rodríguez M; Herrera-Esparza R; Bollain Y Goytia JJ; Pérez-Pérez ME; Pacheco-Tovar D; Murillo-Vázquez J; Pacheco-Tovar G; Avalos-Díaz E
J Immunol Res; 2017; 2017():8959687. PubMed ID: 29318161
[TBL] [Abstract][Full Text] [Related]
17. Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.
Wood DD; Ackerley CA; Brand Bv; Zhang L; Raijmakers R; Mastronardi FG; Moscarello MA
Lab Invest; 2008 Apr; 88(4):354-64. PubMed ID: 18227806
[TBL] [Abstract][Full Text] [Related]
18. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
Raijmakers R; Zendman AJ; Egberts WV; Vossenaar ER; Raats J; Soede-Huijbregts C; Rutjes FP; van Veelen PA; Drijfhout JW; Pruijn GJ
J Mol Biol; 2007 Apr; 367(4):1118-29. PubMed ID: 17303166
[TBL] [Abstract][Full Text] [Related]
19. Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD).
Bonilha VL; Shadrach KG; Rayborn ME; Li Y; Pauer GJ; Hagstrom SA; Bhattacharya SK; Hollyfield JG
Exp Eye Res; 2013 Jun; 111():71-8. PubMed ID: 23562679
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
